Bill
Bill > A01293
NY A01293
NY A01293Provides for reciprocity agreements with other states for medical cannabis programs; directs the cannabis control board to promulgate regulations for the approval of pre-roll products in the medical cannabis program.
summary
Introduced
01/09/2025
01/09/2025
In Committee
01/07/2026
01/07/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the cannabis law, in relation to certain medical cannabis reforms
AI Summary
This bill makes two key changes to New York's cannabis law: First, it allows out-of-state medical cannabis patients to use their medical cannabis in New York under certain conditions, provided they have legitimate documentation from their home state and comply with New York's legal limits on medical cannabis possession, delivery, and production. The cannabis control board is authorized to develop regulations for this reciprocity and potentially create reciprocity agreements with other states that have medical cannabis programs. Second, the bill directs the cannabis control board to create regulations specifically for approving pre-roll (pre-rolled cannabis cigarette) products within the state's medical cannabis program. This means out-of-state medical cannabis patients will now have a legal pathway to use their medical cannabis while visiting New York, and the medical cannabis program will have a standardized process for introducing pre-rolled cannabis products. The bill takes effect immediately upon passage.
Committee Categories
Business and Industry
Sponsors (3)
Last Action
referred to economic development (on 01/07/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/A1293 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=A01293&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#A01293 |
Loading...